semaglutide and bariatric surgery vs. GLP-1 Medications: What the Latest Research Shows Medications like Semaglutide and Tirzepatide

Patients on complex medication regimens, those with kidney disease, or individuals who have failed prior GLP-1 therapy may benefit from PlexusDx's integrated approachcompounded options, optional genetic profiling, and provider consultationrather than a discount-only model

Unfortunately, GLP-1 is rapidly degraded by the enzyme dipeptidyl peptidase-4 (DPP-4), which limits the therapeutic efficacy of native GLP-1 (Deacon et al., 1995)

While these medications have demonstrated anti-inflammatory properties in some metabolic contexts, there is no evidence that these effects translate to meaningful benefits for endometriosis-related inflammation or pain

Vergs, B

Clinically, this translates to improved energy levels, reduced fatigue, and enhanced physical endurance